Advertisement
Perrigo Guides FY24 Well Below Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) initiated its adjusted earnings, revenue and organic net sales growth guidance for the full-year 2024.
For fiscal 2024, the company now projects adjusted earnings in a range of $2.50 to $2.65 per share on flat net sales, with organic net sales growth of 1 to 3 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.99 per share on revenue growth of 4.7 percent to $4.89 billion for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Perrigo Recalls Select CVS Health, H-E-B Baby Premium Infant Formula
Perrigo Co. plc is recalling select Premium Infant Formula with Iron Milk-Based Powder sold under CVS Health and H-E-B Baby brands at the retailer and warehouse level citing elevated Vitamin D levels than permitted, according to the U.S. Food and Drug Administration. The recall involves three lots within one batch, or 16,500 cans, of store brand Premium Infant Formula with Iron Milk-Based Powder.
RTTNews
|
vor 374 Tagen
Perrigo Launches Project Energize To Improve Efficiency, Cut Costs; To Cut 6% Jobs - Update
While reporting financial results for the fourth quarter on Tuesday, consumer products company Perrigo Co. plc (PRGO) said it is launching Project Energize - a global investment and efficiency program to drive the next evolution of capabilities and organizational agility.
RTTNews
|
vor 538 Tagen
Perrigo Appoints Patrick Lockwood-Taylor As President And CEO
Pharma company Perrigo Company plc (PRGO) announced Thursday the appointment of industry professional Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023.
RTTNews
|
vor 802 Tagen
Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S.
Consumer Self-Care Products firm Perrigo Co. plc (PRGO) announced Monday that its company HRA Pharma has submitted its application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the U.S.
RTTNews
|
vor 1134 Tagen
TSX Down Marginally In Lackluster Trade
Canadian stocks are turning in a lackluster performance on Monday as investors closely focusing on the meeting between U.S. President Donald Trump and Ukrainian President Volodymyr Zelenskyy at the White House.
RTTNews
|
vor 34 Minuten
Swiss Market Settles Flat
After a flat start, the Switzerland market turned weak Monday morning and then spent the rest of the day's trading session in negative territory as investors remained reluctant to pick up stocks as they looked ahead to a meeting between U.S. President Donald Trump and several European leaders to discuss the situation in Ukraine.
RTTNews
|
vor 1Std 0 Minuten
European Markets Close On Mixed Note After Cautious Session
European stocks turned in a mixed performance on Monday as investors largely stayed cautious, looking ahead to the meeting between U.S. President Donald Trump and several European leaders, including Ukrainian President Volodymyr Zelenskyy after the Trump-Putin Summit failed to result in any breakthrough to end the war in Ukraine.
RTTNews
|
vor 1Std 18 Minuten
Dollar Extends Losses As Markets Cling On To Fed Cut Hopes
The Dollar extended losses during the week ended August 15 amidst strong Fed rate cut expectations, benign consumer price growth, easing geopolitical concerns as well as fading concerns about trade tariff uncertainty.
RTTNews
|
vor 4Std 0 Minuten
